Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 30;28(1):307.
doi: 10.3390/molecules28010307.

Synthesis and Antiprotozoal Activity of Azabicyclo-Nonane Pyrimidine Hybrids

Affiliations

Synthesis and Antiprotozoal Activity of Azabicyclo-Nonane Pyrimidine Hybrids

Clemens Hinteregger et al. Molecules. .

Abstract

2,4-Diaminopyrimidines and (dialkylamino)azabicyclo-nonanes possess activity against protozoan parasites. A series of fused hybrids were synthesized and tested in vitro against pathogens of malaria tropica and sleeping sickness. The activities and selectivities of compounds strongly depended on the substitution pattern of both ring systems as well as on the position of the nitrogen atom in the bicycles. The most promising hybrids of 3-azabicyclo-nonane with 2-aminopyrimidine showed activity against P. falciparum NF54 in submicromolar concentration and high selectivity. A hybrid with pyrrolidino substitution of the 2-azabicyclo-nonane as well as of the pyrimidine moiety exhibited promising activity against the multiresistant K1 strain of P. falciparum. A couple of hybrids of 2-azabicyclo-nonanes with 2-(dialkylamino)pyrimidines possessed high activity against Trypanosoma brucei rhodesiense STIB900 and good selectivity.

Keywords: Plasmodium falciparum; Trypanosoma brucei rhodesiense; azabicyclo-nonanes; hybrids; pyrimidine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Pyrimethamine, 2-azabicyclo[3.2.2]nonanes and 3-azabicyclo[3.2.2]nonanes.
Scheme 1
Scheme 1
Preparation of compounds 524. Reagents and conditions: (a) corresp. 4-chloropyrimidine, DIPEA, 1-BuOH, 145 °C, 48h; (b) 2,4-dichloro-6-methylpyrimidine, DIPEA, EtOH, 0 °C→RT, 44–188 h; (c) sec. amine, DIPEA, ACN, 105 °C, 20–48h.
Figure 2
Figure 2
Most active compounds.

References

    1. WHO . World Malaria Report 2021. World Health Organization; Geneva, Switzerland: 2021. [(accessed on 29 December 2022)]. Available online: https://www.who.int/teams/global-malaria-programme/reports/world-malaria....
    1. Ashley E.A., Dhorda M., Fairhust R.M., Amaratunga C., Lim P., Suon S., Sreng S., Anderson J.M., Mao S., Sam B., et al. Spread of Artemisinin Restistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2014;371:411–423. doi: 10.1056/NEJMoa1314981. - DOI - PMC - PubMed
    1. Das S., Manna S., Saha B., Hati A.K., Roy S. Novel pfkelch13 Gene Polymorphism Associates with Artemisinin Resistance in Eastern India. Clin. Infect. Dis. 2019;69:1144–1152. doi: 10.1093/cid/ciy1038. - DOI - PubMed
    1. WHO Factsheet. [(accessed on 27 September 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-a...
    1. DNDi Drugs for Neglected Diseases Initiative. [(accessed on 27 September 2022)]. Available online: https://dndi.org/diseases/sleeping-sickness.

LinkOut - more resources